...
首页> 外文期刊>Mayo Clinic Proceedings >Weighing the evidence linking UVB irradiance, vitamin D, and cancer risk
【24h】

Weighing the evidence linking UVB irradiance, vitamin D, and cancer risk

机译:权衡将UVB辐照度,维生素D和癌症风险联系起来的证据

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor. A recent article concluded that evidence of a beneficial role of vitamin D in reducing the risk of cancer incidence and mortality is not impressive, in part because of a lack of good randomized controlled trials (RCTs). Randomized controlled trials are appropriate for studying pharmaceutical drugs but not necessarily for vitamin D. Most vitamin D is produced from solar UVB irradiance and confounds oral intake in RCTs of vitamin D. Nested case-control studies are less reliable than case-control studies because the relation of a single serum 25-hydroxyvitamin D [25(OH)D] level measurement to subsequent serum 25(OH) D levels declines with the passage of time, and undetectable cancers can grow rapidly in the absence of adequate serum 25(OH)D levels.
机译:致编辑。最近的一篇文章得出结论,维生素D在降低癌症发病率和死亡率的风险中发挥有益作用的证据并不令人印象深刻,部分原因是缺乏良好的随机对照试验(RCT)。随机对照试验适用于研究药物,但不一定适用于维生素D。大多数维生素D是通过太阳紫外线照射产生的,并且在维生素D的RCT中混淆了口服摄入。嵌套式病例对照研究的可靠性不如病例对照研究,因为一次血清25-羟基维生素D [25(OH)D]水平测量与随后血清25(OH)D水平之间的关系随着时间的流逝而下降,在缺乏足够血清25(OH)的情况下无法检测到的癌症会迅速生长D级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号